Pfizer to dispose of entire Haleon stake
Portfolio Pulse from
Pfizer plans to sell its entire 7.3% stake in Haleon, a British consumer healthcare group.
March 18, 2025 | 5:15 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Pfizer is selling its entire 7.3% stake in Haleon, which may affect its stock price as investors react to the divestment.
The sale of Pfizer's stake in Haleon could lead to a neutral impact on Pfizer's stock price in the short term. While the divestment may free up capital, it also reduces Pfizer's exposure to the consumer healthcare sector. The market's reaction will depend on how investors perceive this strategic move.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100